GGrantIndex
← Search

Cancer Prevention and Control Research Program

$156,000P30FY2025CANIH

Oregon Health & Science University, Portland OR

Investigators

Linked publications, trials & patents

Paper 39764100Paper 39763867Paper 39605535Paper 39435649Paper 39386578Paper 39375962Trial NCT07434128Trial NCT07278440Trial NCT07089940Trial NCT05705492Trial NCT04247425Trial NCT04172493Trial NCT04104139Trial NCT04061980Trial NCT04005690Trial NCT03961672Trial NCT03960177Trial NCT03699995Trial NCT03677531Trial NCT03649880Trial NCT03626285Trial NCT03613259Trial NCT03544125Trial NCT03479268Trial NCT03418025Trial NCT03406013Trial NCT03361436Trial NCT03347617Trial NCT03325166Trial NCT03280277Trial NCT03270059Trial NCT03261180Trial NCT03234309Trial NCT03135782Trial NCT03097588Trial NCT03028935Trial NCT03010358Trial NCT03009201Trial NCT02890979Trial NCT02869412Trial NCT02857218Trial NCT02779283Trial NCT02736617Trial NCT02522715Trial NCT02504359Trial NCT02503358Trial NCT02501759Trial NCT02498951Trial NCT02427841Trial NCT02359097Trial NCT02355262Trial NCT02312557Trial NCT02228265Trial NCT02100189Trial NCT02099864Trial NCT02092324Trial NCT02070705Trial NCT02050919Trial NCT01913015Trial NCT01748942Trial NCT01689987Trial NCT01649505Trial NCT01635413Trial NCT01620216Trial NCT01532687Trial NCT01498978Trial NCT01441882Trial NCT01422408Trial NCT01253642Trial NCT01031953Trial NCT01005914Trial NCT00983398Trial NCT00978562Trial NCT00900302Trial NCT00900068Trial NCT00900055Trial NCT00899795Trial NCT00899522Trial NCT00843167Trial NCT00822848Trial NCT00764517Trial NCT00722072Trial NCT00691652Trial NCT00662103Trial NCT00660543Trial NCT00659126Trial NCT00627276Trial NCT00516542Trial NCT00482274Trial NCT00425386Trial NCT00324324Trial NCT00303849Trial NCT00293475Trial NCT00253721Trial NCT00253643Trial NCT00238433Trial NCT00227682Trial NCT00103038Trial NCT00075387Patent 9279811

Abstract

PROJECT SUMMARY: Cancer Prevention and Control Research Program Kerri Winters-Stone, Ph.D., and Sue Flocke, Ph.D., Program Co-Leaders The Knight Cancer Institute (KCI) Cancer Prevention and Control (CPC) Program is focused on reducing cancer incidence, morbidity and mortality through innovative approaches that translate knowledge from basic and population health discoveries to at-risk populations and communities. CPC has 38 members conducting research to reduce cancer burden through transdisciplinary collaborative science within three themes: 1) Prevention and Risk Reduction, 2) Early Detection and Screening, and 3) Survivorship. There is also a cross-cutting theme to improve cancer prevention and control for at-risk populations in our catchment area, including low-income, rural, older adults, tribal communities and those with a familial predisposition to cancer. CPC has nearly doubled peer-reviewed direct cost funding since the last cycle from $2,755,855 to $4,822,697, with NCI funding accounting for $3,405,640, an increase of 98%. CPC scientists’ discoveries have resulted in 659 publications; 22% are intra-programmatic, 30% inter-programmatic, 55% are inter-institutional, and 20% are in journals with an impact factor greater than 10. CPC work addresses several of our high-priority cancers, and aims to improve equity in at-risk populations in our catchment area. Highlights include translating discoveries from animal models of cancer cachexia and of young women’s breast cancer to preclinical trials of therapeutic agents; advancing knowledge of the biology of melanoma genetic risk and disease progression to advance our War On Melanoma; leading collaborative research focused on increasing uptake of evidence-based cancer screenings in Oregon’s rural and low-income populations; and improving decision-making and care planning for older patients with advanced lung cancer. CPC members have led updates to national screening guidelines in breast, lung, and colon cancer and evidence- based exercise recommendations for cancer survivors. Program members also lead innovative multi-investigator initiatives. The Healthy Oregon Project led to an inter-programmatic Biden Cancer Moonshot grant, Evaluation of Population Based Testing for HBOC and Lynch Syndromes to develop genetic screening approaches to identify persons at risk for heritable cancers, while a new P50 NCI Implementation Science Center is conducting intervention studies to transform clinical practice and increase delivery of cancer screening services to tens of thousands of low-income community health center patients. CPC members also lead national training programs for under-represented minorities, including cancer control training programs for American Indian and Alaskan Native graduate students and community providers. Plans to further the impactful work of CPC include building infrastructure and networks for research in cancer and aging, amplifying implementation science capacity, and growing our Healthy Oregon Project and War on Melanoma cohorts.

View original record on NIH RePORTER →